Published in Cell Microbiol on November 03, 2013
Influence of PhoP and intra-species variations on virulence of Yersinia pseudotuberculosis during the natural oral infection route. PLoS One (2014) 0.80
Yersinia pestis targets neutrophils via complement receptor 3. Cell Microbiol (2014) 0.79
Yersinia versus host immunity: how a pathogen evades or triggers a protective response. Curr Opin Microbiol (2015) 0.79
Temperature-responsive in vitro RNA structurome of Yersinia pseudotuberculosis. Proc Natl Acad Sci U S A (2016) 0.78
Combinational deletion of three membrane protein-encoding genes highly attenuates yersinia pestis while retaining immunogenicity in a mouse model of pneumonic plague. Infect Immun (2015) 0.78
Transcriptomic and Phenotypic Analysis Reveals New Functions for the Tat Pathway in Yersinia pseudotuberculosis. J Bacteriol (2016) 0.76
Illuminating Targets of Bacterial Secretion. PLoS Pathog (2015) 0.76
Fis Is Essential for Yersinia pseudotuberculosis Virulence and Protects against Reactive Oxygen Species Produced by Phagocytic Cells during Infection. PLoS Pathog (2016) 0.75
Defining the Ail Ligand-Binding Surface: Hydrophobic Residues in Two Extracellular Loops Mediate Cell and Extracellular Matrix Binding To Facilitate Yop Delivery. Infect Immun (2017) 0.75
Yersinia pestis--etiologic agent of plague. Clin Microbiol Rev (1997) 14.63
Complement: a key system for immune surveillance and homeostasis. Nat Immunol (2010) 10.37
Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis. Proc Natl Acad Sci U S A (1999) 10.34
Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J Leukoc Biol (2007) 7.80
Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol (2013) 7.10
Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis. Proc Natl Acad Sci U S A (2004) 5.09
Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis. Annu Rev Microbiol (2005) 4.46
Analysis of the yopA gene encoding the Yop1 virulence determinants of Yersinia spp. Mol Microbiol (1989) 3.43
Identification of the secretion and translocation domain of the enteropathogenic and enterohemorrhagic Escherichia coli effector Cif, using TEM-1 beta-lactamase as a new fluorescence-based reporter. J Bacteriol (2004) 3.41
Plague bacteria target immune cells during infection. Science (2005) 3.32
The Yersinia Ysc-Yop 'type III' weaponry. Nat Rev Mol Cell Biol (2002) 3.22
A general system to integrate lacZ fusions into the chromosomes of gram-negative eubacteria: regulation of the Pm promoter of the TOL plasmid studied with all controlling elements in monocopy. Mol Gen Genet (1992) 3.18
Progression of primary pneumonic plague: a mouse model of infection, pathology, and bacterial transcriptional activity. Proc Natl Acad Sci U S A (2005) 3.01
The yersiniae--a model genus to study the rapid evolution of bacterial pathogens. Nat Rev Microbiol (2003) 2.77
A plasminogen-activating protease specifically controls the development of primary pneumonic plague. Science (2007) 2.69
The Yersinia pseudotuberculosis adhesin YadA mediates intimate bacterial attachment to and entry into HEp-2 cells. Infect Immun (1993) 2.41
Plasmid-mediated surface fibrillae of Yersinia pseudotuberculosis and Yersinia enterocolitica: relationship to the outer membrane protein YOP1 and possible importance for pathogenesis. Infect Immun (1987) 2.40
Binding to collagen by Yersinia enterocolitica and Yersinia pseudotuberculosis: evidence for yopA-mediated and chromosomally encoded mechanisms. J Bacteriol (1989) 2.36
The bacterial injection kit: type III secretion systems. Ann Med (2005) 2.23
Hydrophobic domains affect the collagen-binding specificity and surface polymerization as well as the virulence potential of the YadA protein of Yersinia enterocolitica. Mol Microbiol (1993) 2.13
Role of Yops and adhesins in resistance of Yersinia enterocolitica to phagocytosis. Infect Immun (2002) 1.97
Pathogenesis of defined invasion mutants of Yersinia enterocolitica in a BALB/c mouse model of infection. Infect Immun (1995) 1.92
RovA, a global regulator of Yersinia pestis, specifically required for bubonic plague. Proc Natl Acad Sci U S A (2006) 1.92
Invasin-dependent and invasin-independent pathways for translocation of Yersinia pseudotuberculosis across the Peyer's patch intestinal epithelium. Infect Immun (1997) 1.68
Adhesion protein YadA of Yersinia species mediates binding of bacteria to fibronectin. Infect Immun (1992) 1.66
The ail gene of Yersinia enterocolitica has a role in the ability of the organism to survive serum killing. Infect Immun (1993) 1.65
Requirement of the Yersinia pseudotuberculosis effectors YopH and YopE in colonization and persistence in intestinal and lymph tissues. Infect Immun (2003) 1.64
Invasin expression in Yersinia pseudotuberculosis. Infect Immun (1992) 1.64
Resistance of Yersinia pestis to complement-dependent killing is mediated by the Ail outer membrane protein. Infect Immun (2007) 1.59
The psa locus is responsible for thermoinducible binding of Yersinia pseudotuberculosis to cultured cells. Infect Immun (1996) 1.47
Yersinia controls type III effector delivery into host cells by modulating Rho activity. PLoS Pathog (2008) 1.40
Phenotypic characterization of OmpX, an Ail homologue of Yersinia pestis KIM. Microbiology (2007) 1.39
The YadA protein of Yersinia pseudotuberculosis mediates high-efficiency uptake into human cells under environmental conditions in which invasin is repressed. Infect Immun (2002) 1.37
Identification of a domain in Yersinia virulence factor YadA that is crucial for extracellular matrix-specific cell adhesion and uptake. Proc Natl Acad Sci U S A (2006) 1.36
Reevaluation of the virulence phenotype of the inv yadA double mutants of Yersinia pseudotuberculosis. Infect Immun (1997) 1.36
Yersinia enterocolitica serum resistance proteins YadA and ail bind the complement regulator C4b-binding protein. PLoS Pathog (2008) 1.36
Deletion of amino acids 29 to 81 in adhesion protein YadA of Yersinia enterocolitica serotype O:8 results in selective abrogation of adherence to neutrophils. Infect Immun (1996) 1.30
Role of YadA, Ail, and Lipopolysaccharide in Serum Resistance of Yersinia enterocolitica Serotype O:3. Infect Immun (2005) 1.26
Translocated effectors of Yersinia. Curr Opin Microbiol (2009) 1.25
Immunoglobulin G monoclonal antibodies to Cryptococcus neoformans protect mice deficient in complement component C3. Infect Immun (2002) 1.24
The Yersinia pestis Ail protein mediates binding and Yop delivery to host cells required for plague virulence. Infect Immun (2008) 1.23
Pulmonary infection by Yersinia pestis rapidly establishes a permissive environment for microbial proliferation. Proc Natl Acad Sci U S A (2012) 1.22
The presence of professional phagocytes dictates the number of host cells targeted for Yop translocation during infection. Cell Microbiol (2010) 1.20
Complement-mediated host defense in the lung. Am J Physiol Lung Cell Mol Physiol (2000) 1.20
Role of Yops in inhibition of phagocytosis and killing of opsonized Yersinia enterocolitica by human granulocytes. Infect Immun (1995) 1.19
Yersinia enterocolitica targets cells of the innate and adaptive immune system by injection of Yops in a mouse infection model. PLoS Pathog (2009) 1.16
Transcriptional regulation of the Yersinia pseudotuberculosis pH6 antigen adhesin by two envelope-associated components. Mol Microbiol (1997) 1.16
Mutations in the Yersinia pseudotuberculosis type III secretion system needle protein, YscF, that specifically abrogate effector translocation into host cells. J Bacteriol (2006) 1.16
Yersinia enterocolitica can deliver Yop proteins into a wide range of cell types: development of a delivery system for heterologous proteins. Eur J Cell Biol (2000) 1.14
Three Yersinia pestis adhesins facilitate Yop delivery to eukaryotic cells and contribute to plague virulence. Infect Immun (2010) 1.11
Outer membrane protein X (Ail) contributes to Yersinia pestis virulence in pneumonic plague and its activity is dependent on the lipopolysaccharide core length. Infect Immun (2010) 1.11
Ail binding to fibronectin facilitates Yersinia pestis binding to host cells and Yop delivery. Infect Immun (2010) 1.11
Identification and characterization of small-molecule inhibitors of Yop translocation in Yersinia pseudotuberculosis. Antimicrob Agents Chemother (2010) 1.09
Small molecule inhibitors of LcrF, a Yersinia pseudotuberculosis transcription factor, attenuate virulence and limit infection in a murine pneumonia model. Infect Immun (2010) 1.06
pH6 antigen of Yersinia pestis interacts with plasma lipoproteins and cell membranes. J Lipid Res (2002) 1.05
FGL chaperone-assembled fimbrial polyadhesins: anti-immune armament of Gram-negative bacterial pathogens. FEMS Microbiol Rev (2007) 1.04
Influence of surface modulations by enzymes and monoclonal antibodies on alternative complement pathway activation by Yersinia enterocolitica. Infect Immun (1989) 1.03
Role of complement in innate immunity and infections. Crit Rev Immunol (2010) 1.03
Comparison of YopE and YopT activities in counteracting host signalling responses to Yersinia pseudotuberculosis infection. Cell Microbiol (2006) 1.03
Genetic manipulation of virulence of Yersinia enterocolitica. Contrib Microbiol Immunol (1987) 1.03
Modulation of innate immune responses by Yersinia type III secretion system translocators and effectors. Cell Microbiol (2013) 1.02
Identification of MrtAB, an ABC transporter specifically required for Yersinia pseudotuberculosis to colonize the mesenteric lymph nodes. PLoS Pathog (2012) 1.02
Intranasal inoculation of mice with Yersinia pseudotuberculosis causes a lethal lung infection that is dependent on Yersinia outer proteins and PhoP. Infect Immun (2006) 1.01
Cobra venom factor: Structure, function, and humanization for therapeutic complement depletion. Toxicon (2010) 1.00
Two substrate-targeting sites in the Yersinia protein tyrosine phosphatase co-operate to promote bacterial virulence. Mol Microbiol (2005) 1.00
A NET Outcome. Front Immunol (2012) 1.00
Regulation of the Yersinia type III secretion system: traffic control. Front Cell Infect Microbiol (2013) 1.00
Functional mapping of YadA- and Ail-mediated binding of human factor H to Yersinia enterocolitica serotype O:3. Infect Immun (2008) 0.99
Structural insights into Ail-mediated adhesion in Yersinia pestis. Structure (2011) 0.97
Hepoxilin A(3) facilitates neutrophilic breach of lipoxygenase-expressing airway epithelial barriers. J Immunol (2012) 0.94
Deletion of Braun lipoprotein gene (lpp) and curing of plasmid pPCP1 dramatically alter the virulence of Yersinia pestis CO92 in a mouse model of pneumonic plague. Microbiology (2009) 0.94
Adhesins of human pathogens from the genus Yersinia. Adv Exp Med Biol (2011) 0.93
Role of the Yersinia pestis Ail protein in preventing a protective polymorphonuclear leukocyte response during bubonic plague. Infect Immun (2011) 0.92
Yersinia pestis Ail: multiple roles of a single protein. Front Cell Infect Microbiol (2012) 0.92
Adhesins and host serum factors drive Yop translocation by yersinia into professional phagocytes during animal infection. PLoS Pathog (2013) 0.90
Unique cell adhesion and invasion properties of Yersinia enterocolitica O:3, the most frequent cause of human Yersiniosis. PLoS Pathog (2011) 0.89
Yersinia infection tools-characterization of structure and function of adhesins. Front Cell Infect Microbiol (2013) 0.88
Functional recruitment of the human complement inhibitor C4BP to Yersinia pseudotuberculosis outer membrane protein Ail. J Immunol (2012) 0.87
Ail protein binds ninth type III fibronectin repeat (9FNIII) within central 120-kDa region of fibronectin to facilitate cell binding by Yersinia pestis. J Biol Chem (2012) 0.86
Yersinia enterocolitica YadA mediates complement evasion by recruitment and inactivation of C3 products. J Immunol (2012) 0.86
Oral inoculation with Type III secretion mutants of Yersinia pseudotuberculosis provides protection from oral, intraperitoneal, or intranasal challenge with virulent Yersinia. Vaccine (2006) 0.82
The Yersinia pseudotuberculosis outer membrane protein Ail recruits the human complement regulatory protein factor H. J Immunol (2012) 0.82
A mutant with aberrant extracellular LcrV-YscF interactions fails to form pores and translocate Yop effector proteins but retains the ability to trigger Yop secretion in response to host cell contact. J Bacteriol (2013) 0.82
Yersinia pseudotuberculosis adhesins regulate tissue-specific colonization and immune cell localization in a mouse model of systemic infection. Infect Immun (2006) 0.81
Virulence of Yersinia pseudotuberculosis in aerosol models. Adv Exp Med Biol (2012) 0.76
The influence of age, gender, and race on the prevalence of depression in heart failure patients. J Am Coll Cardiol (2004) 4.55
Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine. Circulation (2004) 3.05
Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease. J Am Coll Cardiol (2005) 2.47
Yersinia pseudotuberculosis disseminates directly from a replicating bacterial pool in the intestine. J Exp Med (2006) 2.11
Self-regulation of Candida albicans population size during GI colonization. PLoS Pathog (2007) 1.85
Requirement of the Yersinia pseudotuberculosis effectors YopH and YopE in colonization and persistence in intestinal and lymph tissues. Infect Immun (2003) 1.64
Anthrax toxin receptor 2 mediates Bacillus anthracis killing of macrophages following spore challenge. Cell Microbiol (2005) 1.42
CD8(+) T cells restrict Yersinia pseudotuberculosis infection: bypass of anti-phagocytosis by targeting antigen-presenting cells. PLoS Pathog (2009) 1.24
The presence of professional phagocytes dictates the number of host cells targeted for Yop translocation during infection. Cell Microbiol (2010) 1.20
Mutations in the Yersinia pseudotuberculosis type III secretion system needle protein, YscF, that specifically abrogate effector translocation into host cells. J Bacteriol (2006) 1.16
Yersinia has a tropism for B and T cell zones of lymph nodes that is independent of the type III secretion system. PLoS Pathog (2006) 1.14
The C-terminal tail of Yersinia pseudotuberculosis YopM is critical for interacting with RSK1 and for virulence. Infect Immun (2010) 1.14
Identification and characterization of small-molecule inhibitors of Yop translocation in Yersinia pseudotuberculosis. Antimicrob Agents Chemother (2010) 1.09
Cytolethal distending toxin family members are differentially affected by alterations in host glycans and membrane cholesterol. J Biol Chem (2010) 1.06
Small molecule inhibitors of LcrF, a Yersinia pseudotuberculosis transcription factor, attenuate virulence and limit infection in a murine pneumonia model. Infect Immun (2010) 1.06
Identification of MrtAB, an ABC transporter specifically required for Yersinia pseudotuberculosis to colonize the mesenteric lymph nodes. PLoS Pathog (2012) 1.02
Intranasal inoculation of mice with Yersinia pseudotuberculosis causes a lethal lung infection that is dependent on Yersinia outer proteins and PhoP. Infect Immun (2006) 1.01
Identifying Yersinia YopH-targeted signal transduction pathways that impair neutrophil responses during in vivo murine infection. Cell Host Microbe (2013) 0.97
The proinflammatory response induced by wild-type Yersinia pseudotuberculosis infection inhibits survival of yop mutants in the gastrointestinal tract and Peyer's patches. Infect Immun (2006) 0.95
A non-invasive quantitative assay to measure murine intestinal inflammation using the neutrophil marker lactoferrin. J Immunol Methods (2006) 0.93
Tolerability of beta-blocker initiation and titration in the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). Circulation (2002) 0.92
Bacterial Secretion Systems: An Overview. Microbiol Spectr (2016) 0.91
Glycogen synthase kinase 3 activation is important for anthrax edema toxin-induced dendritic cell maturation and anthrax toxin receptor 2 expression in macrophages. Infect Immun (2011) 0.90
Adhesins and host serum factors drive Yop translocation by yersinia into professional phagocytes during animal infection. PLoS Pathog (2013) 0.90
ROS-inhibitory activity of YopE is required for full virulence of Yersinia in mice. Cell Microbiol (2010) 0.88
Development of a vaccinia virus based reservoir-targeted vaccine against Yersinia pestis. Vaccine (2010) 0.88
Effect of age on susceptibility to Salmonella Typhimurium infection in C57BL/6 mice. J Med Microbiol (2009) 0.88
Yersinia pestis AcrAB-TolC in antibiotic resistance and virulence. Antimicrob Agents Chemother (2011) 0.86
A dominant-negative needle mutant blocks type III secretion of early but not late substrates in Yersinia. Mol Microbiol (2010) 0.86
Cellular interactions of the cytolethal distending toxins from Escherichia coli and Haemophilus ducreyi. J Biol Chem (2013) 0.84
Mutations in the Pseudomonas aeruginosa needle protein gene pscF confer resistance to phenoxyacetamide inhibitors of the type III secretion system. Antimicrob Agents Chemother (2014) 0.83
Oral inoculation with Type III secretion mutants of Yersinia pseudotuberculosis provides protection from oral, intraperitoneal, or intranasal challenge with virulent Yersinia. Vaccine (2006) 0.82
A mutant with aberrant extracellular LcrV-YscF interactions fails to form pores and translocate Yop effector proteins but retains the ability to trigger Yop secretion in response to host cell contact. J Bacteriol (2013) 0.82
Effect of chronic changes in heart rate on congestive heart failure. J Card Fail (2007) 0.78
Effect of metoprolol on absolute myocardial blood flow in patients with heart failure secondary to ischemic or nonischemic cardiomyopathy. Am J Cardiol (2002) 0.78
Effect of MarA-like proteins on antibiotic resistance and virulence in Yersinia pestis. Infect Immun (2009) 0.77
Cardiac resynchronization therapy for heart failure. N Engl J Med (2002) 0.75